Optimal Research Nominated 2015 Vaccine Industry Excellence (ViE) Award
"Best Clinical Site or Trial Network"
ROCKVILLE, Md., March 25, 2015 /PRNewswire-USNewswire/ -- Optimal Research, LLC has been nominated as a finalist for the Vaccine Industry Excellence (ViE) Award "Best Clinical Site or Trial Network".
This is the second consecutive year that Optimal has been selected as a nominee in this ViE award category at the World Vaccine Congress, receiving a "Highly Recommended" distinction in 2014. The ViE awards were created to honor and generate recognition of the efforts, accomplishments, and positive contributions of companies and individuals in the vaccine industry.
"Optimal Research is honored to be nominated for the second year running," commented
Dr. Stephan Bart, Optimal's President and Chief Medical Officer. "We would like to thank the World Vaccine Congress and the constituent organizations across the industry for their votes of confidence, and the recognition of the work that we do. We have been fortunate to conduct critically important trials this year that we hope will lead to life saving treatments. This testament to the quality, speed, and cost efficient work we deliver to our clients is very rewarding and appreciated."
Optimal will be evaluated by an expert judging panel on a number of site qualities, including rapid enrollment, high subject retention, support of mulitple and diverse vaccine trials, introduction of new services, and overall quality. Award winners will be announced at the Annual World Vaccine Congress being held in Washington, D.C. April 7-9th, 2015.
About Optimal Research
Optimal Research provides clinical site solutions to pharmaceutical and biotech companies, medical device companies, and contract research organizations (CROs) seeking research sites to conduct clinical research studies in a high quality manner. Optimal owns six core sites that focus in conducting trials for vaccines, infectious disease, men's & women's health, and devices. In addition to the core sites that it owns, Optimal utilizes its oncology and pediatric site network to provide integrated site solutions that meet our clients' needs.
Press Contact: Amanda Carroccio, Director of Client Services & Business Development
Phone: 240-238-4917
Email: [email protected]
www.optimalsites.net
Twitter: @OptimalResearch
Logo - http://photos.prnewswire.com/prnh/20150325/194447LOGO
SOURCE Optimal Research
Share this article